Telelytics was a four person seed-stage tech startup, seeking to validate their business model for potential investment. The average deal size was roughly 50k ARR.
Before the pandemic, the medical community viewed remote care with heavy skepticism. The prevailing sentiment among doctors was: "We cannot practice medicine properly if it is remote."
Even more challenging, Telelytics had no external funding, salary, or budget, and likewise no marketing and sales enablement. Furthermore, cold-calls went unanswered since the decision-maker doctor was usually with a patient or not available.
Since cold calling failed, I pivoted strategy and decided to drive in-person to medical offices, physically knock on doors, bought the medical offices lunch, and learned what enablement collateral and features could help the deal.
Angel helped seed stage startup Telelytics feasibility test the Bay Area medical practice market. This provided valuable product feedback, helpful for our investor's acquisition of the technology.